New treatment developed to dramatically slow down the progression of blindness-causing retinal diseases

The Korea Institute of Science and Technology (KIST) announced that Dr. Maesoon Im of the Brain Science Institute, together with Prof. Seung Ja Oh of Kyung Hee University and Prof. Kangwon Lee of Seoul National University, successfully incorporated anti-inflammatory drugs into a hydrogel to suppress inflammation in the retina and effectively deliver the drugs to the inflamed area.

Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2024 Recipient of RPB David F. Weeks Award for Outstanding Vision Research

Patricia Ann D’Amore, PhD, MBA, has been selected as the 2024 RPB David F. Weeks Award for Outstanding Vision Research (Weeks Award). Dr. D’Amore will receive her award and deliver a presentation during the AUPO 2024 Annual Meeting in Austin, Texas in February.

New app developed at NYU Tandon School of Engineering promises to make navigating subway stations easier for people with blindness and low vision

Designed by researchers at NYU Tandon School of Engineering and NYU Grossman School of Medicine, Commute Booster routes public-transportation users through the “middle mile” – the part of a journey inside subway stations or other similar transit hubs – in addition to the “first” and “last” miles that bring travelers to and from those hubs.

King Chulalongkorn Memorial Hospital Doctors Suggest Ways to Prevent Glaucoma through Early Detection

The Excellence Center for Glaucoma, Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, and Thai Glaucoma Society encourage all of us to realize the significance of glaucoma as it is the world’s number 1 cause of irreversible blindness. In Thailand, over 2 million people are affected by glaucoma.

Research to Prevent Blindness Announces New Sight-Saving Vision Research Grants

Research to Prevent Blindness (RPB) announces two new grants to support high-impact vision research. The new grants are the: RPB / Tom Wertheimer Career Development Award in Data Science and RPB / Mary Tyler Moore Vision Initiative Physician-Scientist Award.

新的基因编辑技术成功地逆转小鼠的视力损失

视网膜色素变性症是人类失明的主要原因之一。中国的研究人员成功地恢复了患有视网膜色素变性症的小鼠的视力。该研究将于[三月十七日]发表在《实验医学杂志》上。该研究使用一种新型的、高度通用的CRISPR基因组编辑技术,有潜力纠正各种导致疾病的遗传突变。

New gene-editing technique reverses vision loss in mice

Researchers in China have successfully restored the vision of mice with retinitis pigmentosa, one of the major causes of blindness in humans. The study, to be published March 17 in the Journal of Experimental Medicine, uses a new, highly versatile form of CRISPR-based genome editing with the potential to correct a wide variety of disease-causing genetic mutations.

SLU Researcher, Collaborators Awarded NSF Grant to Create Software System that Generates Accessible STEM Content for Persons with Disabilities

A collaborative team of academia, industry, start-ups, and non-profits, led by Jenna Gorlewicz, Ph.D., associate professor in aerospace and mechanical engineering and associate dean of research and innovation in the School of Science and Engineering at Saint Louis University, was awarded a National Science Foundation (NSF) grant to develop technology to enhance the quality of life, employment access, and opportunities for persons with disabilities.

Research to Prevent Blindness Marks $400 Million in Funding to Advance Eye Disease Research

Research to Prevent Blindness announces a new round of awardees who are generating critical knowledge around a host of sight-threatening conditions. With this latest round of funding, RPB has provided more than $400 million in research funding.

Study Uncovers How Blind and Visually Impaired Individuals Navigate Social Challenges

A recent study highlights the range of uncomfortable situations people living with blindness or visual impairment encounter due to interpersonal communication challenges, and outlines strategies people with visual impairment use to navigate these situations.

Black Patients Found Six Times More Likely to Have Advanced Vision Loss After Glaucoma Diagnosis Than White Patients

Black patients have a dramatically higher risk of advanced vision loss after a new diagnosis of primary open angle glaucoma (POAG) when compared to white patients, according to a new study from New York Eye and Ear Infirmary of Mount Sinai (NYEE).

Blinding Eye Disease Is Strongly Associated With Heart Disease and Stroke

Patients with a specific form of age-related macular degeneration (AMD), a leading cause of blindness in the United States, are at significant risk for cardiovascular disease and stroke, according to new research from New York Eye and Ear Infirmary of Mount Sinai.

American Society of Retina Specialists (ASRS) Launches See for a Lifetime See a Retina Specialist Education Initiative to Drive Awareness and Action Around Retinal Diseases that Put Millions at Risk for Blindness

America’s retina specialists are warning the public that millions in the US who don’t know the facts about common retinal conditions such as age-related macular degeneration (AMD) and diabetic retinopathy are at risk for preventable blindness or vision loss from these sight stealing conditions.

Recycling of the Eye’s Light Sensors Is Faulty in Progressive Blindness of Older Adults

With the National Eye Institute reporting that about 11 million older adults in the U.S. endure a condition that leads to progressive blindness, known as age-related macular degeneration, University of Maryland School of Medicine (UMSOM) researchers are starting to understand what goes wrong in the disease, in order to develop new therapies to treat it.

Mount Sinai Ophthalmologists Develop New Technique to Assess Progression of Sickle Cell Retinopathy

(New York, NY – May 10, 2021)- Ophthalmologists at New York Eye and Ear Infirmary of Mount Sinai have created a new technique to evaluate patients with sickle cell retinopathy and assess the disease before it progresses and leads to…

Audacious projects develop imaging technology to aid eye tissue regeneration

As regenerative therapies for blinding diseases move closer to clinical trials, the National Eye Institute’s functional imaging consortium, a part of the NEI Audacious Goals Initiative (AGI), is pioneering noninvasive technologies to monitor the function of the retina’s light-sensing neurons and their connections to the brain.

Scientists Take Important Step Toward Using Retinal Cell Transplants to Treat Blindness

Retinal cells derived from a cadaver human eye survived when transplanted into the eyes of primate models, an important advance in the development of cell therapy to treat blindness, according to a study published on January 14 in Stem Cell Reports.

Dermatologists warn consumers about the dangers of buying cosmetic injectables — such as fillers — online

A new article published online in the Journal of the American Academy of Dermatology reveals just how common these illicit products are on popular e-commerce sites, increasing the public’s risk for severe and potentially long-term complications, including blindness, disfiguration, and stroke.

Low-Carbohydrate Diet May Be Associated With Lower Risk of Blinding Eye Disease

Following a long-term diet that’s low in carbohydrates and high in fat and protein from vegetables may lower the risk of the most common subtype of glaucoma

Potential Way to Halt Blinding Macular Degeneration Identified

It would be the first treatment for “dry” age-related macular degeneration and could significantly improve treatment for wet AMD.

Research to Prevent Blindness and American Academy of Ophthalmology Award Grants for Big Data Research to Improve Patient Care

The American Academy of Ophthalmology (the Academy) and Research to Prevent Blindness (RPB) today announced this year’s recipients of the Research to Prevent Blindness/American Academy of Ophthalmology Award for IRIS® Registry Research. The grant supports researchers who want to conduct big data research in ophthalmology and blindness prevention.